This study material has been compiled from various sources, including copy-pasted text (likely from a PDF or PowerPoint presentation) and an audio lecture transcript.

📚 Respiratory System: Structure, Defenses, and Disorders

1. Introduction to the Respiratory System

The respiratory system is vital for gas exchange and can be functionally divided into two main parts:

Conducting Airways: These are the passages through which air moves between the atmosphere and the lungs. Their primary role is to ensure air reaches the respiratory tissues.
Respiratory Tissues of the Lungs: This is where the crucial process of gas exchange (oxygen intake, carbon dioxide release) takes place.

2. Respiratory Defense Mechanisms 🛡️

The respiratory system is equipped with sophisticated defenses to protect against inhaled particles and pathogens:

Nasopharyngeal Defenses:
- Function: Remove particles from the air as it enters the body.
- Mechanism: Involves contact with surface lysosomes and immunoglobulins (IgA) to protect against infection.
Glottic and Cough Reflexes:
- Function: Protect against aspiration (entry of foreign material) into the tracheobronchial tree.
- Mechanism: The glottic reflex seals off the airway, while a strong cough reflex expels irritants.
Mucociliary Blanket:
- Components: Mucus and cilia.
- Mucus: Secreted to trap pathogens and dirt particles.
- Cilia: Tiny hair-like structures lining the respiratory tract that rhythmically beat to transport the mucus (with trapped substances) towards the mouth, where it can be swallowed.
- Important Note: Very sticky mucus can impede ciliary movement. An electrolyte solution is secreted to lift the mucus, allowing it to move effectively on a thin fluid layer.
Pulmonary Macrophages:
- Function: Specialized immune cells located within the lungs.
- Mechanism: Remove microorganisms and foreign particles that penetrate deeper into the respiratory system.

3. Obstructive Lung Diseases 💨

Obstructive lung diseases are characterized by a limitation in expiratory airflow. The fundamental problem is increased resistance to airflow due to a reduction in the caliber of conducting airways. This increased resistance can be caused by processes:

Within the lumen (e.g., mucus).
In the airway wall (e.g., inflammation, smooth muscle contraction).
In the supporting structures surrounding the airway (e.g., loss of elasticity).

3.1. Bronchial Asthma 🌬️

📚 Definition: Reversible (though not always completely) airway obstruction, airway inflammation, and hyperresponsiveness to various stimuli. ✅ Prevalence: Most common chronic pulmonary disease, affecting 15-17% in some populations (e.g., Australia, New Zealand); 3-5% in the USA. ✅ Causes: * Allergens * Respiratory tract infections * Hyperventilation, cold air, exercise * Drugs and chemicals * Emotional upsets ✅ Pathogenesis: * Sensitization: Leads to an allergic attack. * Early-phase reaction: Primarily mediated by mast cells. * Late-phase reaction: Involves Th2 lymphocytes and eosinophils. * Th2 lymphocytes release cytokines (e.g., IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13) that activate mast cells, eosinophils, and other effector cells, and drive IgE production by B cells. ✅ Symptoms and Signs: * Cough: Due to airway narrowing, mucus hypersecretion, and neural afferent hyperresponsiveness. * Wheezing: Caused by smooth muscle contraction, mucus hypersecretion, and retention, leading to reduced airway caliber and turbulent airflow. * Dyspnea (shortness of breath) and Chest Tightness: Result from concerted physiological changes. * Tachypnea (rapid breathing) and Tachycardia (rapid heart rate): Universal in acute exacerbations, may be absent in mild disease. * Pulsus Paradoxus: A fall of >10 mm Hg in systolic arterial pressure during inspiration. * Hypoxemia: Due to increasing V/Q (ventilation-perfusion) mismatching with airway obstruction. * Hypercapnia and Respiratory Acidosis: Can occur in severe cases.

3.2. Chronic Obstructive Pulmonary Disease (COPD) 🚬

📚 Definition: A group of respiratory disorders characterized by chronic and recurrent obstruction of airflow in the pulmonary airways.

3.2.1. Chronic Bronchitis

📚 Diagnosis: History of a chronic productive cough for at least 3 months, for at least 2 consecutive years, in the absence of other diseases. ✅ Cause: Cigarette smoking is the principal cause in up to 90% of patients, though only 10-15% of smokers develop COPD, suggesting genetic factors. ✅ Pathologic Features: 1. Inflammation of airways (especially small airways). 2. Hypertrophy of large airway mucous glands, leading to increased mucus secretion and obstruction. * The thickness of mucous glands can be quantified by the Reid index. 3. Mucus-producing goblet cells hypertrophy, and hypersecretion blocks ciliary movement. 4. Mucus and debris accumulate, blocking airways.

3.2.2. Emphysema (Type A COPD, "Pink Puffers")

📚 Definition: Loss of lung elasticity and abnormal, permanent enlargement of air spaces distal to terminal bronchioles, with destruction of alveolar walls and capillary beds, without obvious fibrosis. ✅ Etiology: 1. Smoking: Stimulates inflammatory cell recruitment to alveoli, enhances elastase release from neutrophils, increases elastase activity in macrophages, and activates mast cells (releasing elastases). Smoking also reduces alpha-1 antitrypsin stores. 2. Inherited Deficiency of Alpha-1 Antitrypsin: Accounts for ~1% of COPD cases, more common in younger individuals (<40 years). Inherited as an autosomal recessive disorder, determined by PI (protein inhibitor) genes. ✅ Pathogenesis: Imbalance of local oxidant injury and proteolytic (elastolytic) activity due to a deficiency of protease inhibitors. Oxidants (endogenous like superoxide anion, exogenous like cigarette smoke) inhibit protease inhibitors, leading to progressive tissue destruction.

📊 Comparison of Chronic Bronchitis and Emphysema:

4. Restrictive Lung Diseases 🫁

📚 Definition: Characterized by widespread lung fibrosis, producing increased lung elastic recoil and decreased lung compliance. This is often part of "diffuse parenchymal lung disease," involving infiltration of inflammatory cells, fluid, and scarring of lung parenchyma. ✅ Lung Interstitium: The anatomical space bounded by basement membranes of epithelium and endothelium, containing mesenchymal cells (fibroblasts), extracellular matrix (collagen, elastin, proteoglycans), and tissue leukocytes (mast cells, lymphocytes). ✅ Causes of Interstitial Lung Diseases (Pulmonary Fibrosis): * Collagen-vascular diseases and pulmonary-renal syndromes * Granulomatous (e.g., sarcoidosis, hypersensitivity pneumonitis) * Inherited (e.g., Idiopathic Pulmonary Fibrosis - IPF) * Inhalation causes (occupational/environmental) * Other specific entities (e.g., BOOP, LAM, Eosinophilic pneumonia) ✅ Cellular Events in Lung Injury and Fibrosis: 1. Initial tissue injury. 2. Vascular injury and activation (increased permeability, plasma protein exudation). 3. Epithelial injury and activation (loss of barrier integrity, proinflammatory mediator release). 4. Increased leukocyte adherence and transit into the interstitium. 5. Continued injury and repair, leading to altered cell populations and increased matrix production.

5. Other Respiratory Conditions

5.1. Pneumothorax ⚠️

📚 Definition: An open connection between the pleural space and outside air (thoracic injury) or the alveoli (torn alveolar wall due to overdistension). ✅ Mechanism: Air enters the pleural space, causing the ipsilateral lung to collapse. Breathing is also impaired in the other lung due to mediastinal displacement during inspiration.

5.2. Pulmonary Edema 💧

📚 Definition: Accumulation of excess fluid in the extravascular space of the lungs. Can be slow (e.g., renal failure) or sudden (e.g., acute myocardial infarction). ✅ Etiology (Causes): * Increased Pulmonary Capillary Transmural Pressure: * Increased left atrial pressure (left ventricular failure, mitral valve stenosis, pulmonary venous hypertension). * Increased capillary blood volume (iatrogenic volume expansion, chronic renal failure). * Reduction of interstitial pressure (rapid reexpansion of collapsed lung). * Decreased Plasma Colloid Osmotic Pressure: Hypoalbuminemia (nephrotic syndrome, hepatic failure). * Increased Pulmonary Capillary Endothelial Permeability: Circulating toxins (bacteremia, acute pancreatitis), infectious pneumonia, DIC, nonthoracic trauma ("shock lung"), high-altitude pulmonary edema, cardiopulmonary bypass. * Increased Alveolar Epithelial Permeability: Inhaled toxins (oxygen, phosgene, chlorine, smoke), aspiration of acidic gastric contents, drowning, surfactant depletion (high tidal volume mechanical ventilation). * Reduced Lymphatic Clearance: Lung resection, lymphangitic spread of carcinoma, lung transplant. * Neurogenic Pulmonary Edema: Narcotic overdose, multiple transfusions. ✅ Pathogenesis (Four Factors): * Capillary endothelial permeability * Alveolar epithelial permeability * Hydrostatic pressure * Colloid osmotic pressure * These factors lead to two types: * Cardiogenic: Edema from a net increase in transmural pressure (hydrostatic or osmotic). * Non-cardiogenic: Edema from increased permeability. ✅ Stages of Accumulation: 1. Stage I: Interstitial pulmonary edema. 2. Stage II: Crescentic filling of alveoli. 3. Stage III: Alveolar flooding. ✅ Most Common Causes: 1. Left-sided heart failure or mitral valve disease. 2. Damage to pulmonary blood capillary membranes (e.g., infections like pneumonia, noxious substances like chlorine gas).

5.3. Sleep Apnea 😴

📚 Definition: Absence of spontaneous breathing during sleep. Episodes last ≥10 seconds and can occur 300-500 times per night. ✅ Causes: 1. Blockage of the Upper Airway: Pharyngeal muscles relax during sleep, narrowing the passage and obstructing airflow. 2. "Central" Sleep Apnea: Transient abolition of neural drive to respiratory muscles, due to damage to central respiratory centers or abnormalities of the respiratory neuromuscular apparatus. 💡 Treatment: Continuous Positive Airway Pressure (CPAP) is a common treatment.

5.4. Pulmonary Vascular Disorders 🩸

5.4.1. Pulmonary Embolism

✅ Classic Triad of Symptoms: * Sudden onset of dyspnea (shortness of breath). * Pleuritic chest pain. * Hemoptysis (coughing up blood).

5.4.2. Pulmonary Hypertension 📈

📚 Definition: Elevation of pressure in the pulmonary arterial system. ✅ Normal Pressure: Pulmonary circulation is a low-pressure system; mean pulmonary artery pressure is ~15 mm Hg (28 systolic/8 diastolic). ✅ Causes: * Elevation in left atrial pressure. * Increased pulmonary blood flow. * Increased pulmonary vascular resistance.